People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

A multiple sclerosis specialist shares insights on quiet progression, and discusses research and treatments for MS activity without relapses.

In developing MindGlide the scientists used an initial dataset of 4,247 brain MRI scans from 2,934 MS patients across 592 MRI scanners.

MRI imaging is used to help diagnose many conditions. It can provide images of structures in your body and help show areas of concern. If your doctor thinks you may have multiple sclerosis, an MRI ...

Arrambide G, Tintore M, Espejo C, et al. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain. 2018;141 (4):1075-1084. Baskaran AB, Grebenciucova E, Shoemaker T ...

In brief ETH Zurich researchers have developed a new method of magnetic resonance imaging (MRI) for the early detection and better monitoring of multiple sclerosis (MS). The method maps the myelin ...

Tumefactive multiple sclerosis (MS) is a rare type of MS that causes a tumor-like lesion in your brain. This lesion can press on nearby parts of your brain, leading to many symptoms.

Improved MRI scans of the myelin sheaths in the brain should allow multiple sclerosis to be detected at an early stage. Multiple sclerosis (MS) is a neurological disease that usually leads to ...

Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It affects around 2.9 million people worldwide, and around 15,000 in Switzerland alone.

Study: A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis. Image Credit: New Africa / Shutterstock.com Background ...

Early treatment could slow the onset of multiple sclerosis symptoms, study finds People with very early signs of MS who received the drug in a clinical trial were less likely to develop symptoms.

Garcia-Dominguez MA, Hemond C. Brain atrophy rate is associated with disability progression in multiple sclerosis. Presented at: ACTRIMS Forum 2023; February 23-25; San Diego, CA.